世界のC型肝炎治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hepatitis C Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2786
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、C型肝炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（Rx、OTC）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・C型肝炎治療の市場動向
・企業の競争状況、市場シェア
・C型肝炎治療の種類別市場規模（Rx、OTC）
・C型肝炎治療の用途別市場規模（病院、診療所、その他）
・C型肝炎治療の北米市場規模2016-2027（アメリカ、カナダ）
・C型肝炎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・C型肝炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・C型肝炎治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・C型肝炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AbbVie、Gilead、Kenilworth、Merck、Johnson & Johnson、Bristol-Myers Squibb）
・結論

Market Analysis and Insights: Global Hepatitis C Treatment Market
The global Hepatitis C Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hepatitis C Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hepatitis C Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hepatitis C Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hepatitis C Treatment market.

Global Hepatitis C Treatment Scope and Market Size
Hepatitis C Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis C Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Rx
OTC

Segment by Application
Hospital
Clinic
Other

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Gilead
Kenilworth
Merck
Johnson & Johnson
Bristol-Myers Squibb

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis C Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Rx
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Hepatitis C Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hepatitis C Treatment Market Perspective (2016-2027)
2.2 Hepatitis C Treatment Growth Trends by Regions
2.2.1 Hepatitis C Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hepatitis C Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hepatitis C Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hepatitis C Treatment Industry Dynamic
2.3.1 Hepatitis C Treatment Market Trends
2.3.2 Hepatitis C Treatment Market Drivers
2.3.3 Hepatitis C Treatment Market Challenges
2.3.4 Hepatitis C Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hepatitis C Treatment Players by Revenue
3.1.1 Global Top Hepatitis C Treatment Players by Revenue (2016-2021)
3.1.2 Global Hepatitis C Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hepatitis C Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hepatitis C Treatment Revenue
3.4 Global Hepatitis C Treatment Market Concentration Ratio
3.4.1 Global Hepatitis C Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Treatment Revenue in 2020
3.5 Hepatitis C Treatment Key Players Head office and Area Served
3.6 Key Players Hepatitis C Treatment Product Solution and Service
3.7 Date of Enter into Hepatitis C Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hepatitis C Treatment Breakdown Data by Type
4.1 Global Hepatitis C Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hepatitis C Treatment Forecasted Market Size by Type (2022-2027)

5 Hepatitis C Treatment Breakdown Data by Application
5.1 Global Hepatitis C Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hepatitis C Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hepatitis C Treatment Market Size (2016-2027)
6.2 North America Hepatitis C Treatment Market Size by Type
6.2.1 North America Hepatitis C Treatment Market Size by Type (2016-2021)
6.2.2 North America Hepatitis C Treatment Market Size by Type (2022-2027)
6.2.3 North America Hepatitis C Treatment Market Size by Type (2016-2027)
6.3 North America Hepatitis C Treatment Market Size by Application
6.3.1 North America Hepatitis C Treatment Market Size by Application (2016-2021)
6.3.2 North America Hepatitis C Treatment Market Size by Application (2022-2027)
6.3.3 North America Hepatitis C Treatment Market Size by Application (2016-2027)
6.4 North America Hepatitis C Treatment Market Size by Country
6.4.1 North America Hepatitis C Treatment Market Size by Country (2016-2021)
6.4.2 North America Hepatitis C Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hepatitis C Treatment Market Size (2016-2027)
7.2 Europe Hepatitis C Treatment Market Size by Type
7.2.1 Europe Hepatitis C Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hepatitis C Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hepatitis C Treatment Market Size by Type (2016-2027)
7.3 Europe Hepatitis C Treatment Market Size by Application
7.3.1 Europe Hepatitis C Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hepatitis C Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hepatitis C Treatment Market Size by Application (2016-2027)
7.4 Europe Hepatitis C Treatment Market Size by Country
7.4.1 Europe Hepatitis C Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hepatitis C Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hepatitis C Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hepatitis C Treatment Market Size by Type
8.2.1 Asia-Pacific Hepatitis C Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hepatitis C Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hepatitis C Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hepatitis C Treatment Market Size by Application
8.3.1 Asia-Pacific Hepatitis C Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hepatitis C Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hepatitis C Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hepatitis C Treatment Market Size by Region
8.4.1 Asia-Pacific Hepatitis C Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hepatitis C Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hepatitis C Treatment Market Size (2016-2027)
9.2 Latin America Hepatitis C Treatment Market Size by Type
9.2.1 Latin America Hepatitis C Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hepatitis C Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hepatitis C Treatment Market Size by Type (2016-2027)
9.3 Latin America Hepatitis C Treatment Market Size by Application
9.3.1 Latin America Hepatitis C Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hepatitis C Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hepatitis C Treatment Market Size by Application (2016-2027)
9.4 Latin America Hepatitis C Treatment Market Size by Country
9.4.1 Latin America Hepatitis C Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hepatitis C Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hepatitis C Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hepatitis C Treatment Market Size by Type
10.2.1 Middle East & Africa Hepatitis C Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hepatitis C Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hepatitis C Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hepatitis C Treatment Market Size by Application
10.3.1 Middle East & Africa Hepatitis C Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hepatitis C Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hepatitis C Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hepatitis C Treatment Market Size by Country
10.4.1 Middle East & Africa Hepatitis C Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hepatitis C Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Hepatitis C Treatment Introduction
11.1.4 AbbVie Revenue in Hepatitis C Treatment Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Gilead
11.2.1 Gilead Company Details
11.2.2 Gilead Business Overview
11.2.3 Gilead Hepatitis C Treatment Introduction
11.2.4 Gilead Revenue in Hepatitis C Treatment Business (2016-2021)
11.2.5 Gilead Recent Development
11.3 Kenilworth
11.3.1 Kenilworth Company Details
11.3.2 Kenilworth Business Overview
11.3.3 Kenilworth Hepatitis C Treatment Introduction
11.3.4 Kenilworth Revenue in Hepatitis C Treatment Business (2016-2021)
11.3.5 Kenilworth Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Hepatitis C Treatment Introduction
11.4.4 Merck Revenue in Hepatitis C Treatment Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Hepatitis C Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Hepatitis C Treatment Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Hepatitis C Treatment Introduction
11.6.4 Bristol-Myers Squibb Revenue in Hepatitis C Treatment Business (2016-2021)
11.6.5 Bristol-Myers Squibb Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hepatitis C Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Rx
Table 3. Key Players of OTC
Table 4. Global Hepatitis C Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hepatitis C Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hepatitis C Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hepatitis C Treatment Market Share by Regions (2016-2021)
Table 8. Global Hepatitis C Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hepatitis C Treatment Market Share by Regions (2022-2027)
Table 10. Hepatitis C Treatment Market Trends
Table 11. Hepatitis C Treatment Market Drivers
Table 12. Hepatitis C Treatment Market Challenges
Table 13. Hepatitis C Treatment Market Restraints
Table 14. Global Hepatitis C Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hepatitis C Treatment Market Share by Players (2016-2021)
Table 16. Global Top Hepatitis C Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Treatment as of 2020)
Table 17. Ranking of Global Top Hepatitis C Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hepatitis C Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hepatitis C Treatment Product Solution and Service
Table 21. Date of Enter into Hepatitis C Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hepatitis C Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hepatitis C Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Hepatitis C Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hepatitis C Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hepatitis C Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hepatitis C Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Hepatitis C Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hepatitis C Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hepatitis C Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hepatitis C Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hepatitis C Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hepatitis C Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hepatitis C Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hepatitis C Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hepatitis C Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hepatitis C Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hepatitis C Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hepatitis C Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hepatitis C Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hepatitis C Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hepatitis C Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hepatitis C Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hepatitis C Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hepatitis C Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hepatitis C Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hepatitis C Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hepatitis C Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hepatitis C Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hepatitis C Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hepatitis C Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hepatitis C Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hepatitis C Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hepatitis C Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hepatitis C Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hepatitis C Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hepatitis C Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hepatitis C Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hepatitis C Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Hepatitis C Treatment Product
Table 64. AbbVie Revenue in Hepatitis C Treatment Business (2016-2021) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Gilead Company Details
Table 67. Gilead Business Overview
Table 68. Gilead Hepatitis C Treatment Product
Table 69. Gilead Revenue in Hepatitis C Treatment Business (2016-2021) & (US$ Million)
Table 70. Gilead Recent Development
Table 71. Kenilworth Company Details
Table 72. Kenilworth Business Overview
Table 73. Kenilworth Hepatitis C Treatment Product
Table 74. Kenilworth Revenue in Hepatitis C Treatment Business (2016-2021) & (US$ Million)
Table 75. Kenilworth Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Hepatitis C Treatment Product
Table 79. Merck Revenue in Hepatitis C Treatment Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Hepatitis C Treatment Product
Table 84. Johnson & Johnson Revenue in Hepatitis C Treatment Business (2016-2021) & (US$ Million)
Table 85. Johnson & Johnson Recent Development
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Hepatitis C Treatment Product
Table 89. Bristol-Myers Squibb Revenue in Hepatitis C Treatment Business (2016-2021) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis C Treatment Market Share by Type: 2020 VS 2027
Figure 2. Rx Features
Figure 3. OTC Features
Figure 4. Global Hepatitis C Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Hepatitis C Treatment Report Years Considered
Figure 9. Global Hepatitis C Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Hepatitis C Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Hepatitis C Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Hepatitis C Treatment Market Share by Regions (2022-2027)
Figure 13. Global Hepatitis C Treatment Market Share by Players in 2020
Figure 14. Global Top Hepatitis C Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Hepatitis C Treatment Revenue in 2020
Figure 16. Global Hepatitis C Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Hepatitis C Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Hepatitis C Treatment Market Share by Type (2016-2027)
Figure 20. North America Hepatitis C Treatment Market Share by Application (2016-2027)
Figure 21. North America Hepatitis C Treatment Market Share by Country (2016-2027)
Figure 22. United States Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hepatitis C Treatment Market Share by Type (2016-2027)
Figure 26. Europe Hepatitis C Treatment Market Share by Application (2016-2027)
Figure 27. Europe Hepatitis C Treatment Market Share by Country (2016-2027)
Figure 28. Germany Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hepatitis C Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Hepatitis C Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Hepatitis C Treatment Market Share by Region (2016-2027)
Figure 38. China Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hepatitis C Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Hepatitis C Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Hepatitis C Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hepatitis C Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Hepatitis C Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Hepatitis C Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Hepatitis C Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AbbVie Revenue Growth Rate in Hepatitis C Treatment Business (2016-2021)
Figure 58. Gilead Revenue Growth Rate in Hepatitis C Treatment Business (2016-2021)
Figure 59. Kenilworth Revenue Growth Rate in Hepatitis C Treatment Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Hepatitis C Treatment Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Hepatitis C Treatment Business (2016-2021)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis C Treatment Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

以下、関連資料のご紹介

世界の虚血性肝炎治療市場規模・現状・予測（2021年-2027年）

Global Ischemic Hepatitis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3286 2021年4月 99Pages
QYResearch社発行の本調査資料では、虚血性肝炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（外科的治療、薬物治療）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の肝炎治療市場規模・現状・予測（2021年-2027年）

Global Hepatitis Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z2798 2021年4月 93Pages
QYResearch社発行の本調査資料では、肝炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（B型肝炎ワクチン、抗ウイルス薬）、用途別市場規模（A型肝炎、B型肝炎、C型肝炎、アルコール性肝炎、その他）、主要地域別市場規模（北米、アメリカ、...

世界の肝炎検査診断市場規模・現状・予測（2021年-2027年）

Global Hepatitis Test Diagnosis Market Size, Status and Forecast 2021-2027
QYR2104Z2795 2021年4月 92Pages
QYResearch社発行の本調査資料では、肝炎検査診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（B型肝炎（HBV）、C型肝炎（HCV）、その他肝炎疾患）、用途別市場規模（病院、ナーシングホーム、診断研究所、血液バンク、その他）、主要地域...

世界のB型肝炎ウイルス（HBV）市場規模・現状・予測（2021年-2027年）

Global Hepatitis B Virus (HBV) Market Size, Status and Forecast 2021-2027
QYR2104Z2783 2021年4月 99Pages
QYResearch社発行の本調査資料では、B型肝炎ウイルス（HBV）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、外来手術センター、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の予防用B型肝炎ウイルスワクチン市場規模・現状・予測（2021年-2027年）

Global Prophylactic Hepatitis B Virus Vaccines Market Size, Status and Forecast 2021-2027
QYR2104Z4822 2021年4月 91Pages
QYResearch社発行の本調査資料では、予防用B型肝炎ウイルスワクチンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（B型肝炎、肝硬変、肝細胞癌、肝不全）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の肝炎診断検査市場規模・現状・予測（2021年-2027年）

Global Hepatitis Diagnostics Test Market Size, Status and Forecast 2021-2027
QYR2104Z2792 2021年4月 99Pages
QYResearch社発行の本調査資料では、肝炎診断検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血液検査、画像検査、肝生検）、用途別市場規模（病院、診療所、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、...

世界のB型肝炎治療市場規模・現状・予測（2021年-2027年）

Global Hepatitis B Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z2782 2021年4月 97Pages
QYResearch社発行の本調査資料では、B型肝炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（B型肝炎ワクチン、抗ウイルス薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界のC型肝炎治療薬市場規模・現状・予測（2021年-2027年）

Global Hepatitis C Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z2784 2021年4月 98Pages
QYResearch社発行の本調査資料では、C型肝炎治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗ウイルス剤、免疫調節剤、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の肝炎検査用溶液市場規模・現状・予測（2021年-2027年）

Global Hepatitis Test Solution Market Size, Status and Forecast 2021-2027
QYR2104Z2796 2021年4月 94Pages
QYResearch社発行の本調査資料では、肝炎検査用溶液のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ポリメラーゼ連鎖反応（PCR）、酵素免疫測定法（ELISA）、迅速診断検査（RDT）、等温核酸増幅技術（INAAT）、その他の技術）、用途...

世界のB型肝炎感染症検査市場規模・現状・予測（2021年-2027年）

Global Hepatitis B Infectious Disease Tests Market Size, Status and Forecast 2021-2027
QYR2104Z2780 2021年4月 100Pages
QYResearch社発行の本調査資料では、B型肝炎感染症検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗体、抗原、核酸検査）、用途別市場規模（病院、独立研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の虚血性肝炎治療市場規模・現状・予測（2021年-2027年） Ischemic hepatitis is also known as shock liver is a condition affecting 0.18%–0.50% of inpatient admissions per year. Usually, the affected patient has no abdominal pain symptoms and the diagnosis is based on biochemical blood analysis. In ischemic hepatitis a considerable higher and noticeable inc…
世界の肝炎治療市場規模・現状・予測（2021年-2027年） Hepatitis therapeutics are a serial treatment methods targeting on Hepatitis A, Hepatitis B,Hepatitis C and Alcoholic Hepatitis. With the number of hepatitis patients increasing and more governments concern about hepatitis and its control, hepatitis therapeutics has large potential market value and …
世界のB型肝炎治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hepatitis B Therapeutics Market The global Hepatitis B Therapeutics market size is projected to reach US$ 3061.6 million by 2026, from US$ 2489 million in 2019, at a CAGR of 3.0% during 2021-2026. With industry-standard accuracy in analysis and high data integrit…
世界の肝炎検査診断市場規模・現状・予測（2021年-2027年） Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic condition. Hepatitis testing refer…
世界の予防用B型肝炎ウイルスワクチン市場規模・現状・予測（2021年-2027年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…